Characterization of human cardiac kv1.5 inhibition by the novel atria I-selective antiarrhythmic compound AVE1231

被引:14
作者
Ehrlich, Joachim R. [1 ]
Ocholla, Hellen [1 ]
Ziemek, Daniel [2 ]
Ruetten, Hartmut [2 ]
Hohnloser, Stefan H. [1 ]
Goegelein, Heinz [2 ]
机构
[1] Univ Frankfurt, Div Cardiol, D-60590 Frankfurt, Germany
[2] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany
关键词
ventricular proarrhythmia; acquired long QT syndrome; atrial-selective antiarrhythmic drugs; atrial fibrillation;
D O I
10.1097/FJC.0b013e3181669030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atrial-selective drug therapy represents a novel therapeutic approach for atrial fibrillation management. The aim of the present study was to investigate the mechanism of hKv1.5 channel inhibition by the atrial-selective compound AVE 1231. Methods: Ionic currents were recorded from CHO cells transfected with KCNA5 cDNA with whole-cell patch-clamp technique. The effect of AVE 123 1 on human atrial cell action potentials was explored with a computer model. Results: KCNA5 expression resulted in typical K+ currents that activated and inactivated voltage dependently. Ascending concentrations of AVE1231 (0.1-100 mu M) led to concentration- and voltage-dependent current inhibition (IC50 at +40 mV: 2.0 +/- 0.5 mu M, Hill coefficient 0.69 +/- 0.12). Acceleration of hKv1.5 current inactivation occurred with increasing AVE1231 concentrations, indicating channel inhibition in the open state (eg, tau(fast) at +40 mV: 318 +/- 92 milliseconds under control; 14 +/- 1 milliseconds with 3 mu M, P < 0.05). Using 1/tau(fast) as an approximation of the time course of drug-channel interaction, association rate (K, 1) and dissociation rate (K-1) constants were 8.18 X 10(6) M/s and 45.95 seconds, respectively (K-D = 5.62 mu M). The onset of current inhibition occurred more rapidly with higher concentrations along with a prominent tail current crossover phenomenon after AVE1231 application. Drug inhibition remained effective through a range of stimulation frequencies. Computer modeling. suggested more pronounced prolongation of action potential duration under conditions of atrial remodeling. Conclusion: AVE1231 is an inhibitor of hKv1.5 currents with predominant action on channels in their open state; thus, it may be suitable for the treatment of AE.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 37 条
[1]   Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes [J].
Bachmann, A ;
Gutcher, I ;
Kopp, K ;
Brendel, J ;
Bosch, RF ;
Busch, AE ;
Gögelein, H .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 364 (05) :472-478
[2]  
Baskin EP, 1998, J PHARMACOL EXP THER, V285, P135
[3]   Ionic mechanisms of electrical remodeling in human atrial fibrillation [J].
Bosch, RF ;
Zeng, XR ;
Grammer, JB ;
Popovic, K ;
Mewis, C ;
Kühlkamp, V .
CARDIOVASCULAR RESEARCH, 1999, 44 (01) :121-131
[4]   The ultrarapid and the transient outward K+ current in human atrial fibrillation.: Their possible role in postoperative atrial fibrillation [J].
Brandt, MC ;
Priebe, L ;
Böhle, T ;
Südkamp, M ;
Beuckelmann, DJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (10) :1885-1896
[5]  
Brundel BJJM, 2001, CIRCULATION, V103, P684
[6]   Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations [J].
Caballero, R ;
Gómez, R ;
Núñez, L ;
Moreno, I ;
Tamargo, J ;
Delpón, E .
CARDIOVASCULAR RESEARCH, 2004, 64 (03) :457-466
[7]   Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization [J].
Caballero, R ;
Delpón, E ;
Valenzuela, C ;
Longobardo, M ;
González, T ;
Tamargo, J .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :825-836
[8]   Losartan and its metabolite E3174 modify cardiac delayed rectifier K+ currents [J].
Caballero, R ;
Delpón, E ;
Valenzuela, C ;
Longobardo, M ;
Tamargo, J .
CIRCULATION, 2000, 101 (10) :1199-1205
[9]   Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model [J].
Courtemanche, M ;
Ramirez, RJ ;
Nattel, S .
CARDIOVASCULAR RESEARCH, 1999, 42 (02) :477-489
[10]   Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model [J].
Courtemanche, M ;
Ramirez, RJ ;
Nattel, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (01) :H301-H321